Calcium is a key constituent for maintaining the in vitro properties of platelets suspended in the bicarbonate-containing additive solution M-sol with low plasma levels

Transfusion

Volumn 50, Issue 5, 2010, Pages 1028-1035

  Wagner, Stephen J ^a   Skripchenko, Andrey ^a   Myrup, Andrew ^a   Thompson Montgomery, Dedeene ^a   Awatefe, Helen ^a   Moroff, Gary ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CALCIUM; CITRIC ACID; PADGEM PROTEIN;

APHERESIS; ARTICLE; BLOOD LEVEL; CENTRIFUGATION; DATA ANALYSIS; IN VITRO STUDY; PH; THROMBOCYTE;

BLOOD PLATELETS; BLOOD PRESERVATION; CALCIUM; HUMANS; SODIUM BICARBONATE; SUSPENSIONS;

EID: 77951676596     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02539.x     Document Type: Article

References (24)

1. Rock G, Swenson SD, Adams GA. Platelet storage in a plasma-free medium. Transfusion 1985 25 : 551 6. (Pubitemid 16174466)
2. Holme S, Heaton WA, Courtright M. Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br J Haematol 1987 66 : 233 8. (Pubitemid 17087422)
3. Rock G, White J, Labow R. Storage of platelets in balanced salt solutions: a simple platelet storage medium. Transfusion 1991 31 : 21 5.
4. van der Meer PF, Pietersz RN, Reesink HW. Comparison of two platelet additive solutions. Trans Med 2001 11 : 193 7.
5. van Rhenen DJ, Vermeij H, Kappers-Klunne M, Payrat JM. Evaluation of a new citrate-acetate NaCl platelet additive solution for the storage of white cell-reduced platelet concentrates obtained from half-strength CPD pooled buffy coats. Transfusion 1995 35 : 50 3.
6. Hornsey VS, McColl K, Drummond O, McMillan L, Morrison A, Morrison L, MacGregor IR, Prowse CV. Extended storage of platelets in SSP platelet additive solution. Vox Sang 2006 91 : 41 6. (Pubitemid 43822303)
7. Gulliksson H, Larsson S, Kumlien G, Shanwell A. Storage of platelets in additive solutions: effects of phosphate. Vox Sang 2000 78 : 176 84. (Pubitemid 32062541)
8. Gulliksson H. Platelet additive solutions: current status. Immunohematol 2007 23 : 14 9. (Pubitemid 46608791)
9. Azuma H, Hirayama J, Akino M, Miura R, Kiyama Y, Imai K, Kasai M, Koizumi K, Kakinoki Y, Makiguchi Y, Kobo K, Atsuta Y, Fujihara M, Homma C, Yamamoto S, Kato T, Ikeda H. Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol). Transfusion 2009 49 : 214 8.
10. Vo TD, Cowles J, Heal JM, Blumberg N. Platelet washing to prevent recurrent fibrile reactions to leucocyte-reduced transfusion. Trans Med 2001 11 : 45 7. (Pubitemid 32180321)
11. Heddle NM, Blajchman MA, Meyer RM, Lipton JH, Walker IR, Sher GD, Constantini LA, Patterson B, Roberts RS, Thorpe KE, Levine MN. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 2002 42 : 556 66.
12. Popovsky M, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985 25 : 573 7. (Pubitemid 16174471)
13. Insunza A, Romon I, Gonzalez-Ponte ML, Hoyos A, Pastor JM, Iriondo A, Hermosa V. Implementation of a strategy to prevent TRALI in a regional blood center. Transfus Med 2004 14 : 157 64. (Pubitemid 38623078)
14. Win N, Chapman CE, Bowles KM, Green A, Bradley S, Edmondson D, Wallis JP. How much residual plasma may cause TRALI? Transfus Med 2008 18 : 276 80.
15. Holme S. Effect of additive solutions on platelet biochemistry. Blood Cells 1992 18 : 421 30.
16. Skripchenko A, Myrup A, Thompson-Montgomery D, Awatefe H, Moroff G, Wagner SJ. Effect of plasma levels on the in vitro properties of platelets suspended in additive solution [abstract SP311]. Transfusion 2008 48S : 142A.
17. Hirayama J, Azuma H, Fujihara M, Homma C, Yamamoto S, Ikeda H. Storage of platelets in a novel additive solution (M-sol), which is prepared by mixing solutions approved for clinical use that are not especially for platelet storage. Transfusion 2007 47 : 960 5. (Pubitemid 46802082)
18. Wagner SJ, Myrup A, Awatefe H, Thompson-Montgomery D, Hirayama J, Skripchenko A. Maintenance of platelet in vitro properties of apheresis platelets during 7-day storage in M-sol with a 30-hour interruption of agitation. Transfusion 2008 48 : 2501 7. (Pubitemid 351793501)
19. Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of the in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Transfusion 1998 38 : 31 40. (Pubitemid 28090937)
20. Curvers J, de Wildt-Eggen J, Heeremans J, Scharenberg J, de Korte K, van der Meer PF. Flow cytometric measurement of CD62P (P-selectin) expression on platelets: a multicenter optimization and standardization effort. Transfusion 2008 48 : 1439 46.
21. Bode AP, Miller DT, Toffaletti J. Plasma levels of ionized and total calcium during storage of citrated platelet concentrate. Transfusion 1989 29 : 534 8. (Pubitemid 19198721)
22. Weis-Fogh US. The effect of citrate, calcium, and magnesium ions on the potassium movement across the human platelet membrane. Transfusion 1985 25 : 339 42.
23. López JJ, Redondo PC, Salido GM, Pariente JA, Rosado JA. N, N, N.,N′-tetrakis(2-pyridylmethyl)ethylenediamine induces apoptosis through the activation of caspases-3 and -8 in human platelets. A role for endoplasmic reticulum stress. J Thromb Hemostasis 2009 7 : 992 9.
24. Wadhawan V, Karim ZA, Mukhopadhyay S, Gupta R, Dikshit M, Dash D. Platelet storage under in vitro conditions is associated with calcium-dependent apoptosis-like lesions and novel reorganization in platelet cytoskeleton. Arch Biochem Biophys 2004 422 : 183 90. (Pubitemid 38169365)